Event Review: Sex, Science and Stems Cells – The Future of Human Reproduction

Lancaster University's public lecture Sex, Science and Stem Cells: The Future of Human Reproduction brought together an impressive panel of legal scholars and bioethicists to explore one of the most provocative questions in modern biomedicine: could science one day replace sex in human reproduction?

Chaired by Professor Jo Rycroft-Malone, executive dean of the Faculty of Health and Medicine at Lancaster University, the event offered a thoughtful and accessible entry point into a field that is rapidly reshaping both scientific possibility and societal imagination.

The evening opened with Professor Emma Cave, a specialist in healthcare law at Durham University, who provided a clear and compelling overview of early human development and the role stem cell research may play in illuminating its most mysterious stages. Professor Cave highlighted a persistent 'black box' in embryology: while research on human embryos is strictly regulated up to 14 days post-fertilisation, the critical period between 14 and 21 days – when gastrulation occurs and the embryo starts laying down the fundamental plan for organs and tissues – remains largely inaccessible. Stem-cell-based embryo models, created by reprogramming adult cells rather than through fertilisation, offer a promising workaround.

Professor Cave argued persuasively that these models could improve IVF success rates, enhance understanding of early pregnancy loss (which affects up to 20 percent of pregnancies), and reduce reliance on animal models. Importantly, she stressed that such models are not substitutes for embryos but complementary tools. Her discussion of the 'governance gap', with legislation lagging behind scientific innovation, was particularly striking. Treating embryo models identically to embryos, she suggested, risks stifling valuable research without adequately reflecting their distinct origins. Her talk successfully balanced scientific explanation with ethical nuance, setting a strong foundation for the discussion that followed.

Professor Emily Jackson, from the Faculty of Law at the London School of Economics, then turned to the future, focusing on in vitro gametogenesis (IVG) – the creation of sperm and eggs from stem cells. While still some ten to 20 years away from clinical application, IVG has already been demonstrated in mice, raising profound implications for human reproduction. Professor Jackson outlined how this technology could eliminate the need for donor gametes by allowing people to generate eggs or sperm from their own cells. This would not only address infertility but also disrupt longstanding constraints such as the biological clock, potentially rendering egg freezing and ovarian stimulation obsolete.

Perhaps the most striking aspect of Professor Jackson's talk was her discussion of same-sex reproduction. Research in mice suggests that it may be possible to derive eggs from male cells, opening the possibility for same-sex couples to have genetically related children. At the same time, she acknowledged public ambivalence, particularly around the idea of removing natural reproductive limits. Professor Jackson's presentation was engaging and forward-looking, effectively conveying both the transformative potential and the societal sensitivities surrounding IVG.

The final speaker, Professor Stephen Wilkinson, a specialist in bioethics at Lancaster University, addressed the question of whether emerging reproductive technologies should be publicly funded. Drawing on examples such as uterus transplantation, IVG, and artificial womb technology, Professor Wilkinson outlined key criteria for NHS funding: safety and effectiveness, cost-effectiveness, alignment with healthcare priorities, and ethical acceptability. He also engaged with common objections, including the availability of alternatives like adoption, concerns about overpopulation, and debates over whether infertility constitutes a disease.

While Professor Wilkinson's arguments were rigorous and thought-provoking, this segment of the lecture was somewhat less cohesive than the preceding talks. The breadth of examples occasionally obscured the central thread, and a more focused discussion might have strengthened the overall impact. Nevertheless, his contribution was valuable in grounding the scientific and ethical debates within real-world policy considerations.

The panel discussion that followed was a highlight of the evening, emphasising the importance of public engagement in shaping the future of reproductive technologies. Questions prompted reflection on practical and emotional challenges, such as the storage of large numbers of lab-generated gametes and embryos, and the psychological difficulty of discarding potential 'siblings'. The speakers acknowledged that society is entering largely uncharted territory, where rapid scientific advances outpace established norms and frameworks.

Overall, this lecture succeeded in presenting a complex and evolving field in a way that was both accessible and intellectually stimulating. The talks were well-structured and complementary, moving from scientific foundations to future applications and finally to ethical and policy implications. While the final presentation could have benefited from greater clarity and focus, the event as a whole offered a clear perspective on the future of human reproduction.

As stem cell technologies continue to advance, questions once confined to speculative fiction are becoming increasingly tangible. Events such as this play a crucial role in fostering informed public dialogue – an essential step as we navigate the profound scientific and societal changes that lie ahead.